{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:10:52Z","timestamp":1760299852687,"version":"build-2065373602"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007793","name":"Stiftelsen Kristian Gerhard Jebsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.schres.2019.11.039","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T05:09:38Z","timestamp":1575263378000},"page":"295-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Lipid alterations in adolescents with early-onset psychosis may be independent of antipsychotic medication"],"prefix":"10.1016","volume":"216","author":[{"given":"Kirsten","family":"Wedervang-Resell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-7023","authenticated-orcid":false,"given":"Svein","family":"Friis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Lonning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runar E.","family":"Smelror","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilie","family":"Johannessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Agartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stine M.","family":"Ulven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten B.","family":"Holven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Myhre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2019.11.039_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2016.05.015","article-title":"Treatment of negative symptoms: where do we stand, and where do we go?","volume":"186","author":"Aleman","year":"2017","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2019.11.039_bb0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2019.11.039_bb0015","doi-asserted-by":"crossref","unstructured":"Andreassen, O.A., Djurovic, S., Thompson, W.K., Schork, A.J., Kendler, K.S., O'Donovan, M.C., Rujescu, D., Werge, T., van de Bunt, M., Morris, A.P., McCarthy, M.I., Roddey, J.C., McEvoy, L.K., Desikan, R.S., Dale, A.M., 2013. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am. J. Hum.Genet. 92(2), 197\u2013209.","DOI":"10.1016\/j.ajhg.2013.01.001"},{"issue":"11","key":"10.1016\/j.schres.2019.11.039_bb0020","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaac.2014.08.009","article-title":"Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naive patients","volume":"53","author":"Arango","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2019.11.039_bb0025","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jacl.2017.05.007","article-title":"Lipid and lipoprotein reference values from 133,450 Dutch lifelines participants: age- and gender-specific baseline lipid values and percentiles","volume":"11","author":"Balder","year":"2017","journal-title":"J. Clin. Lipidol."},{"issue":"1","key":"10.1016\/j.schres.2019.11.039_bb0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.plefa.2012.05.005","article-title":"Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells","volume":"87","author":"Bentsen","year":"2012","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"23","key":"10.1016\/j.schres.2019.11.039_bb0035","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study","volume":"338","author":"Berenson","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.schres.2019.11.039_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0447.2007.00992.x","article-title":"Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?","volume":"115","author":"Buckley","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2019.11.039_bb0045","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12966-015-0285-2","article-title":"Multidimensionality of the relationship between social status and dietary patterns in early childhood: longitudinal results from the French EDEN mother-child cohort","volume":"12","author":"Camara","year":"2015","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"issue":"5","key":"10.1016\/j.schres.2019.11.039_bb0050","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1176\/ajp.145.5.578","article-title":"Deficit and nondeficit forms of schizophrenia: the concept","volume":"145","author":"Carpenter","year":"1988","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2019.11.039_bb0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/104012371502700408","article-title":"A meta-analysis of placebo-controlled trials of omega-3 fatty acid augmentation in schizophrenia: possible stage-specific effects","volume":"27","author":"Chen","year":"2015","journal-title":"Ann. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2019.11.039_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/wps.20420","article-title":"Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls","volume":"16","author":"Correll","year":"2017","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2019.11.039_bb0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Crosby","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.schres.2019.11.039_bb0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"10.1016\/j.schres.2019.11.039_bb0075","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.eurpsy.2014.01.007","article-title":"Impact of primary negative symptoms on functional outcomes in schizophrenia","volume":"29","author":"Fervaha","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2019.11.039_bb0080","doi-asserted-by":"crossref","unstructured":"Franco, O.H., Massaro, J.M., Civil, J., Cobain, M.R., O'Malley, B., D'Agostino, R.B., Sr., 2009. Trajectories of entering the metabolic syndrome: the Framingham heart study. Circulation 120(20), 1943\u20131950.","DOI":"10.1161\/CIRCULATIONAHA.109.855817"},{"issue":"4","key":"10.1016\/j.schres.2019.11.039_bb0085","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1176\/appi.ps.201400558","article-title":"Early predictors of ten-year course in first-episode psychosis","volume":"67","author":"Friis","year":"2016","journal-title":"Psychiatr. Serv."},{"issue":"3","key":"10.1016\/j.schres.2019.11.039_bb0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/wps.20167","article-title":"The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia","volume":"13","author":"Galderisi","year":"2014","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2019.11.039_bb0095","first-page":"247","article-title":"Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis","volume":"73","author":"Galling","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2019.11.039_bb0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpsychires.2017.08.009","article-title":"Evidence for altered cell membrane lipid composition in postmortem prefrontal white matter in bipolar disorder and schizophrenia","volume":"95","author":"Ghosh","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2019.11.039_bb0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.schres.2017.10.042","article-title":"Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis","volume":"197","author":"Gjerde","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.11.039_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.schres.2016.09.026","article-title":"Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naive patients with nonaffective psychosis","volume":"179","author":"Greenhalgh","year":"2017","journal-title":"Schizophr. Res."},{"issue":"9","key":"10.1016\/j.schres.2019.11.039_bb0115","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1345\/aph.1L015","article-title":"Antipsychotics and diabetes: an age-related association","volume":"42","author":"Hammerman","year":"2008","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.schres.2019.11.039_bb0120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12887-016-0729-0","article-title":"Dietary patterns of early childhood and maternal socioeconomic status in a unique prospective sample from a randomized controlled trial of prenatal DHA supplementation","volume":"16","author":"Hidaka","year":"2016","journal-title":"BMC Pediatr."},{"issue":"4","key":"10.1016\/j.schres.2019.11.039_bb0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","article-title":"Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis","volume":"4","author":"Hjorthoj","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2019.11.039_bb0130","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2147\/NDT.S119632","article-title":"Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study","volume":"13","author":"Horsdal","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"9","key":"10.1016\/j.schres.2019.11.039_bb0135","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.mp.4001857","article-title":"Subtyping schizophrenia: implications for genetic research","volume":"11","author":"Jablensky","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2019.11.039_bb0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2018.03.016","article-title":"Dietary patterns and physical activity in people with schizophrenia and increased waist circumference","volume":"199","author":"Jakobsen","year":"2018","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.schres.2019.11.039_bb0145","doi-asserted-by":"crossref","first-page":"e1035","DOI":"10.4088\/JCP.15m10479","article-title":"Pretreatment cardiometabolic status in youth with early-onset psychosis: baseline results from the TEA trial","volume":"78","author":"Jensen","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2019.11.039_bb0150","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.106.620864","article-title":"Distribution of lipoproteins by age and gender in adolescents","volume":"114","author":"Jolliffe","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.schres.2019.11.039_bb0155","first-page":"221","article-title":"Phenotypic manifestation of genetic risk for schizophrenia during adolescence in the general population","volume":"73","author":"Jones","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.schres.2019.11.039_bb0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"Jorgensen","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.schres.2019.11.039_bb0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/03014460.2012.759276","article-title":"Growth references for 0-19 year-old Norwegian children for length\/height, weight, body mass index and head circumference","volume":"40","author":"Juliusson","year":"2013","journal-title":"Ann. Hum. Biol."},{"issue":"7","key":"10.1016\/j.schres.2019.11.039_bb0170","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2019.11.039_bb0175","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"2\u20133","key":"10.1016\/j.schres.2019.11.039_bb0180","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.schres.2008.09.023","article-title":"Differences in glucose tolerance between deficit and nondeficit schizophrenia","volume":"107","author":"Kirkpatrick","year":"2009","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2019.11.039_bb0185","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/schbul\/sbx064","article-title":"Primary, enduring negative symptoms: an update on research","volume":"43","author":"Kirkpatrick","year":"2017","journal-title":"Schizophr. Bull."},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.11.039_bb0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.schres.2011.04.005","article-title":"Cholesterol and cognition in schizophrenia: a double-blind study of patients randomized to clozapine, olanzapine and haloperidol","volume":"130","author":"Krakowski","year":"2011","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2019.11.039_bb0195","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0269881112472568","article-title":"Increases in triglyceride levels are associated with clinical response to clozapine treatment","volume":"27","author":"Lally","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2019.11.039_bb0200","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0735-1097(95)00461-0","article-title":"Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine study","volume":"27","author":"Mahoney","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.schres.2019.11.039_bb0205","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41398-018-0366-5","article-title":"Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study","volume":"9","author":"Martinuzzi","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2019.11.039_bb0210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2012.03.001","article-title":"Niacin subsensitivity is associated with functional impairment in schizophrenia","volume":"137","author":"Messamore","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2019.11.039_bb0215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.plefa.2017.06.014","article-title":"The niacin response biomarker as a schizophrenia endophenotype: a status update","volume":"136","author":"Messamore","year":"2017","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.schres.2019.11.039_bb0220","first-page":"757","article-title":"Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention","volume":"5","author":"Millan","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.schres.2019.11.039_bb0225","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.schres.2017.03.031","article-title":"Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: a systematic review and meta-analysis","volume":"190","author":"Misiak","year":"2017","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2019.11.039_bb0230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/schbul\/sbs082","article-title":"Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2019.11.039_bb0235","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2016.05.014","article-title":"Primary and persistent negative symptoms: concepts, assessments and neurobiological bases","volume":"186","author":"Mucci","year":"2017","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2019.11.039_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/met.2009.0068","article-title":"Insulin resistance and metabolic syndrome in the pediatric population","volume":"8","author":"Nelson","year":"2010","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"45","key":"10.1016\/j.schres.2019.11.039_bb0245","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.schres.2019.11.039_bb0250","doi-asserted-by":"crossref","first-page":"e1240","DOI":"10.1038\/tp.2017.211","article-title":"Identification of a plasma signature of psychotic disorder in children and adolescents from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort","volume":"7","author":"O'Gorman","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2019.11.039_bb0255","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.schres.2019.11.039_bb0260","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neuron.2014.10.028","article-title":"New approaches to psychiatric diagnostic classification","volume":"84","author":"Owen","year":"2014","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.schres.2019.11.039_bb0265","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S2215-0366(16)30262-0","article-title":"The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis","volume":"3","author":"Perry","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2019.11.039_bb0270","first-page":"261","article-title":"Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis","volume":"74","author":"Pillinger","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.schres.2019.11.039_bb0275","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1192\/bjp.bp.117.200907","article-title":"Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis","volume":"211","author":"Pillinger","year":"2017","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2019.11.039_bb0280","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1139\/jpn.0733","article-title":"Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment","volume":"32","author":"Procyshyn","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.schres.2019.11.039_bb0285","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nicl.2015.04.025","article-title":"Negative symptoms in schizophrenia are associated with aberrant striato-cortical connectivity in a rewarded perceptual decision-making task","volume":"8","author":"Reckless","year":"2015","journal-title":"Neuroimage. Clin."},{"issue":"10","key":"10.1016\/j.schres.2019.11.039_bb0290","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/070674371506001005","article-title":"Increased risk of obesity and metabolic dysregulation following 12\u202fmonths of second-generation antipsychotic treatment in children: a prospective cohort study","volume":"60","author":"Ronsley","year":"2015","journal-title":"Can. J. Psychiatr."},{"issue":"6865","key":"10.1016\/j.schres.2019.11.039_bb0295","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.schres.2019.11.039_bb0300","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.1983.01790100074010","article-title":"A children's global assessment scale (CGAS)","volume":"40","author":"Shaffer","year":"1983","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2019.11.039_bb0305","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-3956(03)00006-2","article-title":"Potential use of the topical niacin skin test in early psychosis\u2014a combined approach using optical reflection spectroscopy and a descriptive rating scale","volume":"37","author":"Smesny","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2019.11.039_bb0310","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12888-016-1006-3","article-title":"Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study","volume":"16","author":"Solberg","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2019.11.039_bb0315","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.schres.2018.02.047","article-title":"Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - baseline and two-years findings from the CHANGE trial","volume":"199","author":"Storch Jakobsen","year":"2018","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2019.11.039_bb0320","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jpsychires.2013.01.016","article-title":"Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients","volume":"47","author":"Taha","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"9","key":"10.1016\/j.schres.2019.11.039_bb0325","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11886-013-0400-4","article-title":"How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?","volume":"15","author":"Welty","year":"2013","journal-title":"Curr. Cardiol. Rep."},{"issue":"7","key":"10.1016\/j.schres.2019.11.039_bb0330","doi-asserted-by":"crossref","first-page":"e1176","DOI":"10.1038\/tp.2017.152","article-title":"Serum fatty acid patterns in patients with schizophrenia: a targeted metabonomics study","volume":"7","author":"Yang","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2019.11.039_bb0335","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/schbul\/sbv130","article-title":"Prevalence and specificity of the abnormal niacin response: a potential endophenotype marker in schizophrenia","volume":"42","author":"Yao","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.schres.2019.11.039_bb0340","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.clinbiochem.2006.06.012","article-title":"Pediatric reference intervals for lipids and apolipoproteins on the VITROS 5,1 FS chemistry system","volume":"39","author":"Yip","year":"2006","journal-title":"Clin. Biochem."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419305468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996419305468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:32:47Z","timestamp":1760297567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996419305468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":68,"alternative-id":["S0920996419305468"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2019.11.039","relation":{},"ISSN":["0920-9964"],"issn-type":[{"type":"print","value":"0920-9964"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid alterations in adolescents with early-onset psychosis may be independent of antipsychotic medication","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2019.11.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}